PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Rosuvastatin calcium
Presentation Product Chemical substance Chapter Items dispensed
Rosuvastatin 5mg tablets
0212000AAAAADAD
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System 403,012
Rosuvastatin 10mg tablets
0212000AAAAAAAA
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System 364,659
Rosuvastatin 20mg tablets
0212000AAAAABAB
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System 212,528
Rosuvastatin 40mg tablets
0212000AAAAACAC
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System 70,749
Rosuvastatin 5mg capsules
0212000AAAAAFAF
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System 13,518
Rosuvastatin 10mg capsules
0212000AAAAAGAG
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System 9,444
Rosuvastatin 20mg capsules
0212000AAAAAHAH
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System 5,044
Rosuvastatin 15mg tablets
0212000AAAAAJAJ
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System 3,512
Rosuvastatin 30mg tablets
0212000AAAAAKAK
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System 1,358
Rosuvastatin 40mg capsules
0212000AAAAAIAI
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System 1,250
Rosuvastatin 20mg/5ml oral suspension
0212000AAAAAEAE
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System 3
Rosuvastatin 10mg orodispersible tablets sugar free
0212000AAAAANAN
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System No data available
Rosuvastatin 10mg/5ml oral solution sugar free
0212000AAAAALAL
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System No data available
Rosuvastatin 5mg orodispersible tablets sugar free
0212000AAAAAMAM
Rosuvastatin calcium Rosuvastatin calcium Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.